Connect with us

Life Sciences

StartUp Health Welcomes First Five Type 1 Diabetes Startups into T1D Moonshot Fellowship

Meet the Health Transformers who joined Health Transformer University in order to speed up progress on the prevention, management, and cure of Type 1 diabetes.StartUp Health recently announced a program-related investment (PRI) by The Helmsley Charitab…

Published

on

This article was originally published by Stories by StartUp Health on Medium

Meet the Health Transformers who joined Health Transformer University in order to speed up progress on the prevention, management, and cure of Type 1 diabetes.

StartUp Health recently announced a program-related investment (PRI) by The Helmsley Charitable Trust to provide education, support, and investment to scientists, entrepreneurs, and innovators who are working on the prevention, management, and cure of Type 1 diabetes (T1D). The PRI puts significant firepower behind StartUp Health’s T1D Moonshot, a bold new initiative to organize entrepreneurs, innovators, philanthropists, institutions, industry leaders, and families in order to collaborate to develop and scale breakthrough T1D innovation.

With Helmsley’s philanthropic support, 25 to 30 early-stage T1D startups may be selected by StartUp Health to participate for three years in the T1D track of Health Transformer University, StartUp Health’s education program for healthcare innovators. This entrepreneurial mastery program and lifelong learning community is for ambitious founders and funders who are working together to solve the biggest health challenges of our time.

We are pleased to introduce the first five companies selected into the program below. StartUp Health’s call for innovation remains open as we seek additional founders working to improve the lives of people with Type 1 diabetes.

Journey Biosciences is on a mission to fundamentally improve diabetes care. Driven by science, the company develops predictive screening tools that help proactively detect, manage, and prevent diabetes-related complications.

Health Transformers: Adam Graybill, CEO & Co-founder; Paul Beisswenger, MD, CSO & Co-founder
Location: Cleveland, OH
Learn MoreConnect

enhance-d is committed to changing the status-quo by enhancing diabetes care through a digital self-management experience. The company combines real-time diagnostics across every aspect of the digital diabetes experience with AI-powered analytics and visualizations to see, diagnose, and explain glucose management.

Health Transformers: Federico Fontana, PhD, CEO & Co-founder; Fabio Saviozzi, CCO & Co-founder; Sam Scott, PhD, CSO & Co-founder; Felipe Mattioni Maturana, PhD, CTO & Co-founder
Location: Bern, Switzerland
Connect

Undermyfork keeps track of how specific meals affect your diabetes to help you get it right and adjust your lifestyle according to your body data. What you eat is the cornerstone of your diabetes management; the company keeps track of how specific meals affect your Time in Range.

Health Transformers: Mike Ushakov, CEO & Co-founder; Eugene Molodkin, Co-founder
Location: Hermosa Beach, CA
Connect

Rezq Bio is an early-stage biotech company that seeks to cure Type 1 diabetes (T1D) and other localized autoimmune conditions. The company’s lead asset is a phase 1b/2a ready dendritic cell therapy that treats early-onset Type 1 diabetes.

Health Transformer: Arjun Hattiangadi, CEO
Location: Pittsburgh, PA
Connect

DreaMed Diabetes is on a moonshot mission to create a world where everyone has access to expert care. Using data, the company provides cutting-edge diabetes technology for insulin treatment optimization.

Health Transformer: Eran Atlas, CEO & Co-founder
Location: Petah Tikva, Israel
Connect

Call for T1D Innovation

Are you a scientist or innovator focused on T1D innovation who would benefit from education about how to navigate and build a company that will be successful in attracting mission-aligned capital, customers, and collaborators to pursue scientific discoveries in the field of Type 1 Diabetes? Learn more and apply for a T1D Fellowship.

Become a Health Moonshot Champion

Health moonshots are fueled by passionate families, foundations, and industry organizations committed to achieving health moonshots. Learn how you can join other champions of the T1D Moonshot or one of our other global health moonshots.

Passionate about breaking down health barriers? If you’re an entrepreneur or investor, contact us to learn how you can join our Health Equity Moonshot.

Funders: Learn how you can become a Health Moonshot Champion and invest in Health Transformers.

Founders: Don’t make the journey alone. Learn how Health Transformer University fuels your health moonshot.

Follow us on social media for daily updates on Health Transformers: Twitter, LinkedIn, Facebook, and Instagram.


StartUp Health Welcomes First Five Type 1 Diabetes Startups into T1D Moonshot Fellowship was originally published in StartUp Health on Medium, where people are continuing the conversation by highlighting and responding to this story.

diagnostics
cell therapy
biotech
healthcare
ai

Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending